These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1459499)

  • 1. [Withdrawal reactions after clomipramine].
    Zemishlany Z; Aizenberg D; Hermesh H; Weizman A
    Harefuah; 1992 Oct; 123(7-8):252-5, 307. PubMed ID: 1459499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Withdrawal syndrome from antidepressive drugs. Report of 5 cases].
    Lejoyeux M; Rodière-Rein C; Adès J
    Encephale; 1992; 18(3):251-5. PubMed ID: 1299596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports.
    Sovner R
    Ment Retard; 1995 Aug; 33(4):221-5. PubMed ID: 7565144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant withdrawal phenomena.
    Dilsaver SC; Greden JF
    Biol Psychiatry; 1984 Feb; 19(2):237-56. PubMed ID: 6324897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective evaluation of antidepressant discontinuation].
    Mourad I; Lejoyeux M; Adès J
    Encephale; 1998; 24(3):215-22. PubMed ID: 9696914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A self-administered questionnaire to measure cigarette withdrawal symptoms: the Cigarette Withdrawal Scale.
    Etter JF
    Nicotine Tob Res; 2005 Feb; 7(1):47-57. PubMed ID: 15804677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological distress and adaptational problems associated with benzodiazepine withdrawal and outcome: a replication.
    O'Connor KP; Marchand A; Bélanger L; Mainguy N; Landry P; Savard P; Turcotte J; Dupuis G; Harel F; Lachance L
    Addict Behav; 2004 May; 29(3):583-93. PubMed ID: 15050676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
    Durand C; Mary S; Brazo P; Dollfus S
    Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].
    Dervaux A; Vicart S; Lopes F; Le Borgne MH
    Encephale; 2001; 27(2):194-7. PubMed ID: 11407273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The jitteriness syndrome in panic disorder patients treated with antidepressants.
    Pohl R; Yeragani VK; Balon R; Lycaki H
    J Clin Psychiatry; 1988 Mar; 49(3):100-4. PubMed ID: 3346196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic symptoms in headache patients: the influence of headache diagnosis, frequency, and comorbidity.
    Maizels M; Burchette R
    Headache; 2004; 44(10):983-93. PubMed ID: 15546261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study.
    Freye E; Levy J
    Eur J Pain; 2000; 4(3):307-11. PubMed ID: 10985875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.